Wall Street analyst estimates for Sintx Technologies, Inc. (SINT): consensus price target, buy/hold/sell recommendations and forecasts for revenue, EPS and EBITDA for the upcoming fiscal years.
Sintx Technologies, Inc. is an advanced materials enterprise dedicated to researching, developing, and commercializing medical devices crafted from silicon nitride. These innovative products serve biomedical, industrial, and antipathogenic uses, primarily marketed across the United States.
Analyst Consensus
| Strong Buy | 0 |
| Buy | 2 |
| Hold | 1 |
| Sell | 0 |
| Strong Sell | 0 |
| Total analysts | 3 |
| Avg rating (1-5) | 0.67 |
Valuation Ratios
| Price / Book | 1.69 |
| EV / EBITDA | -0.92 |
| Dividend Yield | 0.00% |
Income Statement (10y)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $15.2M | $11.2M | $95000 | $689000 | $594000 | $606000 | $601000 | $2.6M | $1.2M | $1.0M |
| Cost of Revenue | $3.8M | $6.4M | $56000 | $551000 | $475000 | $449000 | $265000 | $784000 | $811000 | $1.2M |
| Gross Profit | $11.4M | $4.9M | $39000 | $138000 | $119000 | $157000 | $336000 | $1.8M | $435000 | -$201000 |
| Research & Development | $6.3M | $5.1M | $3.0M | $3.4M | $4.8M | $5.9M | $6.5M | $8.7M | $5.2M | $4.6M |
| Selling, General & Admin | $16.6M | $10.9M | $4.7M | $3.3M | $5.1M | $4.9M | $5.3M | $5.4M | $4.6M | $6.4M |
| Operating Expenses | $23.0M | $15.9M | $7.7M | $6.7M | $8.6M | $10.8M | $11.7M | $15.2M | $14.5M | $10.5M |
| Operating Income | -$11.5M | -$11.1M | -$13.1M | -$6.6M | -$8.5M | -$10.6M | -$11.3M | -$13.4M | -$14.0M | -$10.7M |
| EBITDA | -$8.3M | -$11.1M | -$8.2M | -$4.3M | -$6.5M | -$8.6M | -$11.1M | -$6.6M | -$9.6M | -$9.7M |
| Interest Expense | $4.5M | $1.3M | $1.4M | $4000 | $2000 | $25000 | $17000 | $2000 | $29000 | $52000 |
| Pre-tax Income | -$16.6M | -$9.3M | -$9.7M | -$4.8M | -$7.0M | -$9.3M | -$12.0M | -$8.3M | -$11.0M | -$10.4M |
| Income Tax | $6.3M | $1.3M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $6.7M |
| Net Income | -$16.6M | -$9.3M | -$8.7M | -$4.8M | -$7.0M | -$9.3M | -$12.0M | -$8.3M | -$11.0M | -$17.1M |
| EPS | $-32255.41 | $-9395.07 | $-2373.00 | $-311.65 | $-44.57 | $-47.59 | $-54.67 | $-35.43 | $-14.87 | $-6.16 |
| EPS (Diluted) | $-32255.41 | $-9395.07 | $-2253.98 | $-311.65 | $-41.92 | $-39.75 | $-51.96 | $-19.42 | $-15.19 | $-6.16 |
| Shares Outstanding (Diluted) | $515 | $993 | $3839 | $15559 | $174461 | $247102 | $317323 | $425211 | $744781 | $2.8M |
Price
| Price | $1.68 |
| Market Cap | $11M |
| Exchange | NASDAQ |
| Country | US |
Related companies: DHAI · HSCS · IINN · LFWD · PFSA · PTHL · RNAZ
Explore sector: Healthcare · Medical - Devices
More sections of SINT: Overview · Financials · Valuation · Statistics · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks